Neuroscientist Greg Gerdeman challenges researchers to study cannabis science and therapeutics.
The 2016 meeting of ICRS focused on the latest cannabinoid research and the endocannabinoid system.
Dr. Ethan Russo discusses clinical endocannabinoid deficiency and ways to target the ECS for therapeutic benefit.
Data shows that CBD interacts directly with the CB1 receptor and modulates THC’s psychoactivity.
Dr. Bonni Goldstein discusses using cannabis for epilepsy, cancer, autism, and other conditions.
Greg Gerdeman discusses brain science, the neurobiology of stress, and the ECS.
Kevin McKernan discusses sequencing the cannabis genome and its implications.
Evidence shows marijuana users are much less likely to develop metabolic syndrome.
CBD offers hope for a non-toxic therapy to treat aggressive cancer without the painful side effects of chemotherapy.
Olive oil’s many health benefits may be mediated by the endocannabinoid system.